Skip to content

Randomized controlled study of treatment of functional constipation by middle and lower digestive tract washing microbiota transplantation

Randomized controlled study of treatment of functional constipation by middle and lower digestive tract washing microbiota transplantation

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046193
Enrollment
Unknown
Registered
2021-05-09
Start date
2021-04-27
Completion date
Unknown
Last updated
2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional constipation

Interventions

Experimental Group A:Fecal microbiota transplantation of the middle digestive tract
Experimental Group A:Fecal microbiota transplantation of the lower digestive tract

Sponsors

The First Affiliated Hospital of Guangdong Pharmaceutical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Meet the Roman IV diagnostic criteria for chronic functional constipation; 2.These patients have poor response to traditional dietary regulation and drug therapy; 3.Aged 18 to 80 years, gender unlimited.

Exclusion criteria

Exclusion criteria: 1.Abdominal surgery exclude drug metabolism disorder endocrine disorder caused by constipation; 2.Malignant neoplasms, especially gastrointestinal neoplasms, were present; 3.Combined with serious heart, lung, liver and kidney and other important organ function failure disease; 4.Combined with serious mental illness can not cooperate; 5.Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
WexnerChronic atrophic gastritis with intestinal metaplasia;Bristol stool form scale;Gastrointestinal quality of life index;patient assessment of cinstipation symptom;Self-rating anxiety scale;Self-rating Depression Scale;Number of independent defecation;symptoms;Intestinal barrier;

Secondary

MeasureTime frame
Immunological indicators;Inflammatory indicators;Intestinal flora 16SrRNAsequencing;

Countries

China

Contacts

Public ContactWu Lihao

The First Affiliated Hospital of Guangdong Pharmaceutical University?

1920778519@qq.com+86 13660635861

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026